Fingerprint
Dive into the research topics of 'S0941: A phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
S0941: A phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
A. B. El-Khoueiry, C. Rankin, A. B. Siegel, S. Iqbal, I. Y. Gong, K. C. Micetich, O. R. Kayaleh, H. J. Lenz, C. D. Blanke
Research output: Contribution to journal › Article › peer-review
107
Scopus
citations